Personal tools

FFCP PHASE1:Mm9::chr18:21130153..21130163,+: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
Line 1: Line 1:
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=112|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr18:21130153..21130163,+|id=chr18:21130153..21130163,+|ontology_enrichment_celltype=CL:0000325!1.66e-44!2;CL:0000217!1.66e-44!2;CL:0000328!1.66e-44!2;CL:0002573!1.66e-44!2;CL:0002376!1.66e-44!2;CL:0000218!1.66e-44!2;CL:0000692!1.66e-44!2;CL:0002377!1.66e-44!2;CL:0002375!1.66e-44!2;CL:0000215!4.03e-30!3;CL:0000630!4.03e-30!3;CL:0000333!7.63e-10!10;CL:0000095!7.63e-10!10;CL:0000243!7.63e-10!10;CL:0000123!7.63e-10!10;CL:0000125!7.63e-10!10;CL:0000030!7.63e-10!10;CL:0000339!7.63e-10!10|ontology_enrichment_celltype_v019_2=CL:0000217,4.52e-44,2;CL:0000328,4.52e-44,2;CL:0002573,4.52e-44,2;CL:0002376,4.52e-44,2;CL:0000218,4.52e-44,2;CL:0000692,4.52e-44,2;CL:0002377,4.52e-44,2;CL:0002375,4.52e-44,2;CL:0000215,5.61e-30,3;CL:0000333,4.12e-10,10;CL:0000095,4.12e-10,10;CL:0000243,4.12e-10,10;CL:0000123,4.12e-10,10;CL:0000125,4.12e-10,10;CL:0000030,4.12e-10,10;CL:0000339,4.12e-10,10|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000010!4.82e-09!11|ontology_enrichment_uberon_v019_2=UBERON:0000010,2.51e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.681535739998656,3.55186332501892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274561413188081,0,0,0.312037673114561,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr18:21130153..21130163,+}}
{{FFCP
|DHSsupport=NA
|DPIdataset=NA
|EntrezGene=NA
|HGNC=
|MCL_coexpression_id=112
|TSSclassifier=NA
|UniProt=NA
|association_with_transcript=NA
|cluster_id=chr18:21130153..21130163,+
|description=CAGE_peak_at_chr18:21130153..21130163,+
|id=chr18:21130153..21130163,+
|ontology_enrichment_celltype=CL:0000325!1.66e-44!2;CL:0000217!1.66e-44!2;CL:0000328!1.66e-44!2;CL:0002573!1.66e-44!2;CL:0002376!1.66e-44!2;CL:0000218!1.66e-44!2;CL:0000692!1.66e-44!2;CL:0002377!1.66e-44!2;CL:0002375!1.66e-44!2;CL:0000215!4.03e-30!3;CL:0000630!4.03e-30!3;CL:0000333!7.63e-10!10;CL:0000095!7.63e-10!10;CL:0000243!7.63e-10!10;CL:0000123!7.63e-10!10;CL:0000125!7.63e-10!10;CL:0000030!7.63e-10!10;CL:0000339!7.63e-10!10
|ontology_enrichment_celltype_v019_2=CL:0000217,4.52e-44,2;CL:0000328,4.52e-44,2;CL:0002573,4.52e-44,2;CL:0002376,4.52e-44,2;CL:0000218,4.52e-44,2;CL:0000692,4.52e-44,2;CL:0002377,4.52e-44,2;CL:0002375,4.52e-44,2;CL:0000215,5.61e-30,3;CL:0000333,4.12e-10,10;CL:0000095,4.12e-10,10;CL:0000243,4.12e-10,10;CL:0000123,4.12e-10,10;CL:0000125,4.12e-10,10;CL:0000030,4.12e-10,10;CL:0000339,4.12e-10,10
|ontology_enrichment_disease=
|ontology_enrichment_disease_v019_2=
|ontology_enrichment_uberon=UBERON:0000010!4.82e-09!11
|ontology_enrichment_uberon_v019_2=UBERON:0000010,2.51e-09,11
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.681535739998656,3.55186332501892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274561413188081,0,0,0.312037673114561,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|short_description=p@chr18:21130153..21130163,+
}}

Latest revision as of 14:08, 5 August 2015

Short description:p@chr18:21130153..21130163, +
Species:Mouse (Mus musculus)
DPI dataset: NA
TSS-like-by-RIKEN-classifier(Yes/No): NA
DHS support(Yes/No): NA
Description: CAGE_peak_at_chr18:21130153..21130163, +
Coexpression cluster:MCL_coexpression_mm9:112
Association with transcript: NA
EntrezGene:NA
Link to Zenbu:ZENBU


View on UCSC genome browser


Mouse over to see Genome browser image, Click image to go to Genome browser


CAGE Expression




0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0




  • Click each plot point to find sample in table


Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data